Posted on 3/28/18
Interpace Diagnostics Announces Agreement with Acupath Laboratories
PARSIPPANY, N.J., March 28, 2018 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG), a fully integrated commercial and bioinformatics company that provides clinically useful molecular diagnostic tests . . .
Posted on 3/28/18
New Boy Scout Troop Focused on Health Starts in North Philadelphia
Health Partners Plans (HPP), an innovative managed care organization, is sponsoring a new Boy Scout Troop that aims to improve health outcomes and provide a safe . . .
Posted on 3/28/18
PTC Therapeutics Announces Proposed Public Offering of Common Stock
PTC Therapeutics, Inc. (Nasdaq: PTCT) announced today that it is commencing a public offering of 4,000,000 shares of its common stock. All of the shares in . . .
Posted on 3/27/18
Alamo Pharma Services Partners with Thingee Corp.
DOYLESTOWN, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- Alamo Pharma Services (“Alamo”) and Thingee Corporation (“Thingee”) have announced a strategic partnership utilizing Thingee’s iDetail platform that . . .
Posted on 3/27/18
Antares Pharma Provides XYOSTED Regulatory Update
EWING, N.J., March 27, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) today announced that the official minutes from the Type A meeting with the U.S. . . .
Posted on 3/27/18
Recro Pharma Announces Publication of Phase III IV Meloxicam Bunionectomy Data in the Clinical Journal of Pain
MALVERN, Pa., March 27, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other . . .
Posted on 3/27/18
Better Stock: Verizon Communications Inc. (VZ) vs. Johnson & Johnson (JNJ)
Johnson & Johnson (NYSE:JNJ) and Verizon (NYSE:VZ) have long been bastions of bountiful dividend income for investors. With the stocks of the healthcare colossus and telecom . . .
Posted on 3/27/18
Is Pfizer's Best Option Now a Consumer Healthcare Spinoff?
More doors are closing than opening for Pfizer (NYSE:PFE) with regard to the big drugmaker's options for its consumer healthcare business. Pfizer announced in October that . . .
Posted on 3/27/18
Don't Worry, Pfizer Isn't Out of Options for Its Consumer Health Division Just Yet
Last October, Pfizer (NYSE:PFE) announced that it was reviewing strategic alternatives for its consumer healthcare division that sells over-the-counter products, such as Advil and Centrum vitamins. . . .
Posted on 3/26/18
Better Buy: Johnson & Johnson vs. Merck
The healthcare industry has many massive players, but they tend to concentrate on different areas of the market. Johnson & Johnson (NYSE:JNJ) is a true healthcare . . .
Posted on 3/26/18
Arena Pharmaceuticals Takes Aim at Celgene
On Monday, Arena Pharmaceuticals (NASDAQ:ARNA) unveiled mid-stage trial results for etrasimod, an S1P-modulating drug that works similarly to ozanimod, one of Celgene's (NASDAQ:CELG) most anticipated drugs. . . .
Posted on 3/26/18
Is Merck & Co. Inc. a Buy?
Several big pharma stocks have performed relatively well over the last 12 months. But not Merck & Co. (NYSE:MRK). The drugmaker actually claims one of the . . .
Posted on 3/23/18
Better Buy: Celgene Corporation vs. Biogen Inc.
It's been a great decade to own stocks in general, but those of you who bought Celgene Corporation (NASDAQ:CELG) or Biogen, Inc. (NASDAQ:BIIB) back in 2008 . . .
Posted on 4/2/18
Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec To Manufacture Universal Donor Cell Therapies
SEATTLE and PHILADELPHIA, March 21, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal donor cell therapies for patients with hematologic malignances and other . . .
Posted on 3/21/18
Johnson & Johnson: Dividend Hike Ahead
Johnson & Johnson (NYSE:JNJ) has incurred a 12% correction during the last two months. Nevertheless, most of its shareholders have a long-term perspective and thus hold . . .
Posted on 3/21/18
Celgene: A High-Growth Stock Trading At A Cheap Price
Celgene (CELG) offers a good combination of value and growth at the current price. The company trades at 10.5 price to forward-looking earnings and the earnings . . .
Posted on 3/20/18
Forbes Magazine Names CSL Limited Among Top 50 Employers in the World
Forbes has named global biotechnology leader CSL Limited among the world's Top 50 employers, landing at no. 42 in the business media's annual Global 2000 survey.The . . .
Posted on 3/27/18
Konica Minolta’s Exa Platform Helps Green Bay Radiology Grow While Streamlining Operations
WAYNE, N.J., March 20, 2018 (GLOBE NEWSWIRE) -- Konica Minolta Healthcare Americas, Inc. announces that Green Bay Radiology installed Konica Minolta’s Exa™ PACS at several of . . .
Posted on 3/20/18
Is Pfizer's CEO Ian Read Really Worth 61% More?
A proxy filed with the Securities and Exchange Commission shows that Pfizer (NYSE:PFE) paid CEO Ian Read $27.9 million in 2017, a 61% increase over the . . .
Posted on 3/20/18
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 13, 2018 it approved non-statutory stock options to purchase an aggregate of 25,200 shares of its . . .
Posted on 3/16/18
Johnson & Johnson To Divest LifeScan Unit For $2.1B
Johnson & Johnson (NYSE:JNJ) announces that it has received a $2.1B binding offer from private equity shop Platinum Equity for its LIfeScan glucose monitoring business.The deadline . . .
Posted on 3/16/18
How Pfizer Plans to Move Into the Big Leagues for Cancer Treatment
Pfizer (NYSE:PFE) ranks as the biggest drugmaker in the world in terms of prescription drug sales. But the company hasn't really been at the forefront in . . .
Posted on 3/16/18
Hackensack Meridian Health and Carrier Clinic Explore Partnership
Hackensack MeridianHealth, New Jersey's largest most comprehensive and integrated health network, and Carrier Clinic, a leader in behavioral health with a 100-year history in the state, . . .
Posted on 3/15/18
Pfizer (PFE) Presents at Cowen and Company Health Care Conference (Transcript)
Pfizer (NYSE:PFE) Cowen and Company Health Care Conference Call March 14, 2018 10:40 AM ETExecutivesAndy Schmeltz - Global President of OncologyChris Boshoff - SVP, Immuno-OncologyAnalystsSteve Scala . . .
Posted on 3/15/18
Updating Our Thoughts On Celgene
Image Source: Celgene Q4 2017 earnings presentation.Pipeline Woes ContinueThe share price of Celgene (CELG) was accelerating heading into the Fall of 2017 as the strength of . . .

